Archives

by in
Entry Author Date Location
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
The Fiscal Cliff Is Forcing a Biomedical Day of Reckoning 12/31/12 National
2012: The Year When Genomic Medicine Started Paying Off 12/17/12 National
The Wisconsin Biotech Story: Slow and Steady Wins the Race 12/10/12 Wisconsin
Where’s the Can-Do Spirit in Biotech? It’s Alive, Deep Down 12/03/12 National
San Diego Life Sciences Roundup: Acadia, RQx, and Venture Funding 11/30/12 San Diego
The Few and the Proud: The Biotech Startup Class of 2012 11/26/12 National
Stanford’s Mike Snyder is Showing the Way With Personalized Medicine 11/19/12 National
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Which VCs Are Poised to Cash In On the Biotech IPOs of 2012? 10/15/12 National
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
The FDA Turns Friendly Toward Pharma in 2012 09/10/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
A Lonely Voice Asking Tough Questions on Cancer Cost-Effectiveness 07/30/12 National
Scarcity of Samples Threatens Personalized Medicine 07/23/12 National
A Summer Reading List for Biotech Pros 07/16/12 National
The Best Boring Companies in Biotech 07/09/12 National
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Page 3 of 6 « previous page · next page »